Enhancing the efficacy of TCR gene therapy
TCR gene therapy allows redirection of the antigen specificity of T cells by the introduction of novel TCR α and β chains by retroviral transduction. These TCR gene modified T cells can be adoptively transferred to target defined tumour antigens. The majority of TCR gene therapy studies has focused...
Main Author: | Nicholson, E. K. |
---|---|
Published: |
University College London (University of London)
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.617922 |
Similar Items
-
Characterising the role of dendritic cells in TCR gene therapy
by: Hotblack, A. C.
Published: (2017) -
Lentiviral TCR gene transfer for tumour immunotherapy
by: Perro, M.
Published: (2010) -
Stochastic modelling of TCR binding
by: Currie, James
Published: (2012) -
Regulation of TCR signalling by SOCS
by: Barry, A. C.
Published: (2008) -
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
by: Emma Nicholson, et al.
Published: (2012-01-01)